Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Full October 2008 Issue in PDF

  • STD Quarterly: NIAID will not move forward with HIV vaccine trial — What's next step in vaccine research?

    Rewind to 2007. A large HIV vaccine clinical trial sponsored by Merck & Co. is shuttered after an interim analysis concluded that the vaccine did not prevent infection. Fast forward to today.
  • Council, Segal honored for development efforts

    The Population Council, a New York City-based reproductive health research organization, and Sheldon Segal, PhD, distinguished scientist at the council, have been scheduled to receive the 2008 Prix Galien USA Pro Bono Humanum Award for their role in developing implantable hormone delivery systems.
  • Clinic waiting room video reduces new STDs

    As you move through your busy day at the clinic, how are you providing important sexually transmitted disease (STD) prevention messages to your patients? If caseload and budgetary restrictions are impeding your intentions, take a look at using a brief waiting room video intervention to complement your efforts.
  • STD Quarterly: Simplifying consent eases testing stigma

    What is your clinic's policy when it comes to getting a signed informed consent for HIV testing? By eliminating required written consent for HIV testing at the San Francisco Department of Public Health Medical Center, the average monthly rate of HIV tests has increased by 4.38 per 1,000 patient-visits, with a 67% increase (from 8.9 to 14.9) in the monthly average number of new positive HIV tests.
  • Be on the lookout for Internet STD drugs

    Talk with your patients about fraudulent drugs sold over the Internet as treatment for sexually transmitted diseases (STDs). The Food and Drug Administration (FDA) has issued warning letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the Internet to U.S. consumers for STD prevention and treatment.
  • Incorporating end-of-life issues into education

    End-of-life issues should be discussed while people are in good health. Just as people prepare for birth, it is important to prepare for death.
  • ACS, NMA join to reduce cancer disparities

    The American Cancer Society in Atlanta and the National Medical Association in Washington, DC, have joined the strengths of their respective organizations targeted to end disparities in cancer treatment and diagnosis among ethnic minority and underserved population groups.
  • Pharma industry revises ethics provisions

    "In interacting with the medical community, we are committed to following the highest ethical standards, as well as all legal requirements. We are also concerned that our interactions with health care professionals not be perceived as inappropriate by patients or the public at large. This Code is to reinforce our intention that our interactions with health care professionals are professional exchanges designed to benefit patients and to enhance the practice of medicine."
  • Points for organizing an ethics committee

    Editor's note: Medical Ethics Advisor is beginning an occasional series with articles designed to help provide useful information in the organizing and administration of ethics committees.